Jinli Feng received her doctoral degree in Neurology from the Chinese PLA Medical School, China. She currently works as an attending physician in the Senior Department of Neurology at the Chinese PLA General Hospital, Beijing, China. Her research focuses on central nervous system infections, particularly central nervous system tuberculosis and mechanisms of tuberculosis-associated neural injury, as well as amyotrophic lateral sclerosis (ALS). She has published more than 20 articles, contributed to two books, and received funding for two key institutional research projects. Her representative publications include studies on CNS tuberculosis (BMC Infectious Diseases, 2025;25:1482), m6A-SNP-related diagnostic biomarkers in ALS (Frontiers in Immunology, 2026;17:1914869), and inflammatory biomarkers for predicting mortality in critically ill patients with stroke (Frontiers in Neurology, 2023;14:1110347). She also serves as a reviewer for BMC Neurology, Current Neuropharmacology, and Neuropsychiatric Research.